[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT784476E - Tratamento da esclerose multipla (em) e outras condicoes desmielinizantes utilizando lofepramina em combinacao com l-fenilalanina tirosina ou triptofano e opcionalmente um composto da vitamina b 12 - Google Patents

Tratamento da esclerose multipla (em) e outras condicoes desmielinizantes utilizando lofepramina em combinacao com l-fenilalanina tirosina ou triptofano e opcionalmente um composto da vitamina b 12

Info

Publication number
PT784476E
PT784476E PT95933488T PT95933488T PT784476E PT 784476 E PT784476 E PT 784476E PT 95933488 T PT95933488 T PT 95933488T PT 95933488 T PT95933488 T PT 95933488T PT 784476 E PT784476 E PT 784476E
Authority
PT
Portugal
Prior art keywords
combination
multiple sclerosis
demelinizing
triptofan
lofepramine
Prior art date
Application number
PT95933488T
Other languages
English (en)
Inventor
Cari Loder
Original Assignee
Cari Loder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420116A external-priority patent/GB9420116D0/en
Priority claimed from GBGB9508482.8A external-priority patent/GB9508482D0/en
Application filed by Cari Loder filed Critical Cari Loder
Publication of PT784476E publication Critical patent/PT784476E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Control Of El Displays (AREA)
PT95933488T 1994-10-05 1995-10-05 Tratamento da esclerose multipla (em) e outras condicoes desmielinizantes utilizando lofepramina em combinacao com l-fenilalanina tirosina ou triptofano e opcionalmente um composto da vitamina b 12 PT784476E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420116A GB9420116D0 (en) 1994-10-05 1994-10-05 A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions
GBGB9508482.8A GB9508482D0 (en) 1995-04-26 1995-04-26 A therapeutic drug treatment for compensating for the effects of nerve damage caused by multiple sclerosis and other demyelinating conditions, and the product

Publications (1)

Publication Number Publication Date
PT784476E true PT784476E (pt) 2003-03-31

Family

ID=26305745

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95933488T PT784476E (pt) 1994-10-05 1995-10-05 Tratamento da esclerose multipla (em) e outras condicoes desmielinizantes utilizando lofepramina em combinacao com l-fenilalanina tirosina ou triptofano e opcionalmente um composto da vitamina b 12

Country Status (19)

Country Link
US (2) US6096737A (pt)
EP (1) EP0784476B1 (pt)
JP (1) JPH10508583A (pt)
AT (1) ATE227124T1 (pt)
AU (1) AU710339B2 (pt)
CA (1) CA2200761C (pt)
CZ (1) CZ293873B6 (pt)
DE (1) DE69528773T2 (pt)
DK (1) DK0784476T3 (pt)
ES (1) ES2184808T3 (pt)
FI (1) FI116659B (pt)
HU (1) HU225493B1 (pt)
IS (1) IS1956B (pt)
NO (1) NO314486B1 (pt)
NZ (1) NZ293642A (pt)
PL (1) PL181802B1 (pt)
PT (1) PT784476E (pt)
SK (1) SK281932B6 (pt)
WO (1) WO1996011009A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE224733T1 (de) * 1996-07-05 2002-10-15 Wwk Trust Zusammensetzungen zur behandlung der peripheren neuropathie, die antidepressiven verbindungen und/oder monoamino-oxidaseinhibitoren und/oder vitamin b12 und/oder neurotransmitter-vorläufer oder induktoren enthalten
GB9617990D0 (en) 1996-08-29 1996-10-09 Scotia Holdings Plc Treatment of pain
EP0835660A1 (en) * 1996-10-14 1998-04-15 Gaston Edmond Filomena Merckx Products containing methylcobalamin for the treatment of multiple sclerosis or other demyelinating conditions
US7232830B2 (en) * 1998-06-26 2007-06-19 Elaine A Delack Method for treatment of neurodegenerative diseases and effects of aging
GB9904252D0 (en) * 1999-02-24 1999-04-21 Worsley Andrew P Composition for the treatment of pain
GB9906808D0 (en) * 1999-03-24 1999-05-19 Kilgowan Limited Formulation for treatment of pain
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
DK1311269T3 (da) 2000-08-04 2012-03-26 Dmi Biosciences Inc Fremgangsmåde til anvendelse af diketopiperaziner og sammensætning, som indeholder dem
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US20020147206A1 (en) * 2001-04-05 2002-10-10 Pfizer Inc. Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy
GB0216027D0 (en) 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US6833142B2 (en) * 2002-03-14 2004-12-21 Duane Bennett Formulation for the prevention and treatment of multiple sclerosis and other demyelinating conditions
JP4674317B2 (ja) 2002-10-02 2011-04-20 ディエムアイ アクイジション コーポレイション 疾病の判定および監視
CA2514061A1 (en) * 2003-02-14 2004-09-02 Combinatorx, Incorporated Combination therapy for the treatment of immunoinflammatory disorders
EP2517719B1 (en) 2003-05-15 2016-03-30 Ampio Pharmaceuticals, Inc. Treatment of T-cell mediated diseases
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
US20050192261A1 (en) * 2003-09-15 2005-09-01 Jost-Price Edward R. Methods and reagents for the treatment of immunoinflammatory disorders
CA2643892A1 (en) * 2006-02-24 2007-09-07 Shire Llc Antidepressant prodrugs
US8217047B2 (en) * 2008-05-27 2012-07-10 Dmi Acquisition Corp. Therapeutic methods and compounds
WO2011011594A2 (en) * 2009-07-23 2011-01-27 Shriners Hospitals For Children Intracellular toll-like receptors pathways and axonal degeneration
WO2012033792A2 (en) 2010-09-07 2012-03-15 Dmi Acquisition Corp. Treatment of diseases
MX362164B (es) 2011-10-10 2019-01-07 Ampio Pharmaceuticals Inc Tratamiento de enfermedad de articulacion degenerativa.
CN103841934A (zh) 2011-10-10 2014-06-04 安皮奥制药股份有限公司 增强免疫耐受的可植入的医疗装置及其制造与植入方法
SG11201400283RA (en) 2011-10-28 2014-03-28 Ampio Pharmaceuticals Inc Treatment of rhinitis
BR112015020469A2 (pt) 2013-03-15 2020-01-28 Ampio Pharmaceuticals Inc Usos de da-dkp, composição e método para fornecimento de células-tronco a umindivíduo
WO2016028790A1 (en) 2014-08-18 2016-02-25 Ampio Pharmaceuticals, Inc. Treatment of joint conditions
WO2016209969A1 (en) 2015-06-22 2016-12-29 Ampio Pharmaceuticals, Inc. Use of low molecular weight fractions of human serum albumin in treating diseases
WO2017085437A1 (en) 2015-11-19 2017-05-26 The Wwk Trust Combinations for the treatment of dementia, and the enhancement of cognitive function
CA3041358A1 (en) * 2016-10-25 2018-05-03 Uti Limited Partnership Treatment for progressive multiple sclerosis
WO2018200381A1 (en) 2017-04-25 2018-11-01 Temple Otorongo Llc Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
EP3431491A1 (en) * 2017-07-18 2019-01-23 Centre National De La Recherche Scientifique Methods for purifying proteins having a tubulin carboxypeptidase activity and peptidic based inhibitors thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497306A (en) * 1975-07-03 1978-01-05 Leo Ab Preparation of lofepramine and its hydrochloride
GB2082910A (en) * 1980-08-28 1982-03-17 Berk Pharmaceuticals Ltd Anti-depressant compositions
US4409243A (en) * 1981-11-09 1983-10-11 Julian Lieb Treatment of auto-immune and inflammatory diseases
GB2129299A (en) * 1982-11-09 1984-05-16 Alec James Coppen Pharmaceutical compositions
DE3519687A1 (de) * 1985-06-01 1986-12-04 Veit Arend Aminosaeuren enthaltendes arzneimittel
US4650789A (en) * 1985-10-15 1987-03-17 Commonwealth Medical Corporation Of America Method and composition for increasing production of serotonin
US4843071A (en) * 1986-12-05 1989-06-27 Serotonin Industries Of Charleston Method and composition for treating obesity, drug abuse, and narcolepsy
DE4204102C2 (de) * 1992-02-12 1998-09-24 Kragler Peter Arzneimittel zur Behandlung und/oder Prophylaxe von AIDS und anderen verwandten Erkrankungen

Also Published As

Publication number Publication date
HU225493B1 (en) 2007-01-29
DE69528773D1 (de) 2002-12-12
HUT77380A (hu) 1998-04-28
CZ293873B6 (cs) 2004-08-18
AU3612695A (en) 1996-05-02
NZ293642A (en) 1998-10-28
FI116659B (fi) 2006-01-31
ATE227124T1 (de) 2002-11-15
FI971290A0 (fi) 1997-03-26
FI971290A (fi) 1997-06-02
JPH10508583A (ja) 1998-08-25
PL319830A1 (en) 1997-09-01
AU710339B2 (en) 1999-09-16
WO1996011009A1 (en) 1996-04-18
CZ99597A3 (en) 1997-11-12
NO971539D0 (no) 1997-04-04
CA2200761A1 (en) 1996-04-18
EP0784476B1 (en) 2002-11-06
DK0784476T3 (da) 2003-03-17
EP0784476A1 (en) 1997-07-23
CA2200761C (en) 2008-02-26
NO971539L (no) 1997-04-04
PL181802B1 (en) 2001-09-28
IS1956B (is) 2004-11-15
SK281932B6 (sk) 2001-09-11
NO314486B1 (no) 2003-03-31
DE69528773T2 (de) 2003-09-04
US6569850B1 (en) 2003-05-27
SK43897A3 (en) 1998-08-05
US6096737A (en) 2000-08-01
ES2184808T3 (es) 2003-04-16
IS4454A (is) 1997-03-26

Similar Documents

Publication Publication Date Title
PT784476E (pt) Tratamento da esclerose multipla (em) e outras condicoes desmielinizantes utilizando lofepramina em combinacao com l-fenilalanina tirosina ou triptofano e opcionalmente um composto da vitamina b 12
DE69636343D1 (de) Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
PT880350E (pt) Tratamento de esclerose multipla
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
ATE235901T1 (de) Pharmazeutische zusammensetzung enthaltend 3-(2,2,2-trimethylhydrazinium)proprionat und gamma- butyrobetain für die behandlung von herz-gefäss- erkrankungen
BR9809673A (pt) Derivados de triptolida úteis no tratamento de doenças autoimunes
KR960003741A (ko) 조골세포 증식인자
DE69733321D1 (de) Olanzapine zur behandlung von drogenmissbrauch
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
UA8278A (uk) Спосіб лікування псоріазу
ATE280584T1 (de) Verwendung von beta interferon zur herstellung eines arzneimittels zur behandlung von ewings sarkom und eoe
RU94045317A (ru) Способ лечения вилюйского энцефаломиелита
RU94037731A (ru) Способ лечения рассеянного склероза
UA19610A (uk) Спосіб лікуваhhя опісторхозhої іhвазії
RU94033502A (ru) Способ лечения детей, больных вторичным панкреатитом
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.